Hymeglusin

CAS: 29066-42-0

Ref. 3D-EBA06642

Información del producto

• Nombre: Hymeglusin
• Sinónimos: (2E,4E,7R)-11-[(2R,3R)-3-(Hydroxymethyl)-4-oxo-2-oxetanyl]-3,5,7-trimethyl-2,4-undecadienoic acid, (2E,4E,7R)-11-[(2R,3R)-3-(hydroxymethyl)-4-oxooxetan-2-yl]-3,5,7-trimethylundeca-2,4-dienoic acid, 11-[3(R)-(Hydroxymethyl-4-oxooxetan-2(R)-yl]-3,5,7(R)-trimethyl-2(E),4(E)-undecadienoic acid, 1233A, 2,4-Undecadienoic acid, 11-[(2R,3R)-3-(hydroxymethyl)-4-oxo-2-oxetanyl]-3,5,7-trimethyl-, (2E,4E,7R)-, 2,4-Undecadienoic acid, 11-[3-(hydroxymethyl)-4-oxo-2-oxetanyl]-3,5,7-trimethyl-, [2R-[2α(2E,4E,7R*),3β]]-, Antibiotic 1233A, Antibiotic F 244, F-244, L-659699
• CAS: 29066-42-0

Descripción

Hymeglusin is a broad-spectrum antiviral drug that inhibits the synthesis of proteins in cells. It reversibly inhibits protein synthesis by binding to the hydroxyl group on the fatty acid side chain of eukaryotic elongation factor 2 (eEF2). Hymeglusin has been shown to be effective against hepatitis C virus (HCV) and human immunodeficiency virus (HIV). This compound has also been shown to inhibit the growth of leukemia cells, HL-60 and K562, in a model system.

• Marca: Biosynth

Propiedades químicas

• Peso molecular: 324.41 g/mol
• Fórmula: C₁₈H₂₈O₅
• Pureza: Min. 95%